<?xml version='1.0' encoding='utf-8'?>
<document id="12639164"><sentence text="Warfarin and amoxicillin/clavulanate drug interaction."><entity charOffset="0-8" id="DDI-PubMed.12639164.s1.e0" text="Warfarin" /><entity charOffset="13-24" id="DDI-PubMed.12639164.s1.e1" text="amoxicillin" /><entity charOffset="25-36" id="DDI-PubMed.12639164.s1.e2" text="clavulanate" /><pair ddi="false" e1="DDI-PubMed.12639164.s1.e0" e2="DDI-PubMed.12639164.s1.e0" /><pair ddi="false" e1="DDI-PubMed.12639164.s1.e0" e2="DDI-PubMed.12639164.s1.e1" /><pair ddi="false" e1="DDI-PubMed.12639164.s1.e0" e2="DDI-PubMed.12639164.s1.e2" /><pair ddi="false" e1="DDI-PubMed.12639164.s1.e1" e2="DDI-PubMed.12639164.s1.e1" /><pair ddi="false" e1="DDI-PubMed.12639164.s1.e1" e2="DDI-PubMed.12639164.s1.e2" /></sentence><sentence text="To report a case of warfarin-amoxicillin/clavulanate potassium (AM/CL) interaction resulting in an elevated international normalized ratio (INR) and hematuria"><entity charOffset="20-28" id="DDI-PubMed.12639164.s2.e0" text="warfarin" /><entity charOffset="41-62" id="DDI-PubMed.12639164.s2.e1" text="clavulanate potassium" /><entity charOffset="67-69" id="DDI-PubMed.12639164.s2.e2" text="CL" /><pair ddi="false" e1="DDI-PubMed.12639164.s2.e0" e2="DDI-PubMed.12639164.s2.e0" /><pair ddi="false" e1="DDI-PubMed.12639164.s2.e0" e2="DDI-PubMed.12639164.s2.e1" /><pair ddi="false" e1="DDI-PubMed.12639164.s2.e0" e2="DDI-PubMed.12639164.s2.e2" /><pair ddi="false" e1="DDI-PubMed.12639164.s2.e1" e2="DDI-PubMed.12639164.s2.e1" /><pair ddi="false" e1="DDI-PubMed.12639164.s2.e1" e2="DDI-PubMed.12639164.s2.e2" /></sentence><sentence text="" /><sentence text="A 58-year-old Hawaiian/Asian/European woman developed an elevated INR and microscopic hematuria as a result of a drug-drug interaction between warfarin and AM/CL"><entity charOffset="159-160" id="DDI-PubMed.12639164.s4.e0" text="CL" /></sentence><sentence text="" /><sentence text="Our report of an increased INR with bleeding complications as a result of an interaction between warfarin and AM/CL is consistent with those in the literature"><entity charOffset="113-114" id="DDI-PubMed.12639164.s6.e0" text="CL" /></sentence><sentence text=" Although the mechanism for this interaction is not fully known, it is suspected that a decrease in vitamin K-producing gut flora with resulting vitamin K deficiency would be the most likely contributing factor"><entity charOffset="145-154" id="DDI-PubMed.12639164.s7.e0" text="vitamin K" /></sentence><sentence text=" An objective causality assessment revealed that this adverse drug event as a result of the warfarin and AM/CL interaction was possible"><entity charOffset="108-116" id="DDI-PubMed.12639164.s8.e0" text="CL" /></sentence><sentence text="" /><sentence text="An increased INR secondary to warfarin interactions with various antibacterial agents is a known phenomenon" /><sentence text=" An increased awareness of warfarin-AM/CL interaction and appropriate monitoring are essential to control the INR levels and prevent bleeding complications"><entity charOffset="39-40" id="DDI-PubMed.12639164.s11.e0" text="CL" /></sentence><sentence text="" /></document>